These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 36779343)

  • 1. Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies.
    Gallagher CI; Ha DA; Harvey RJ; Vandenberg RJ
    Pharmacol Rev; 2022 Oct; 74(4):933-961. PubMed ID: 36779343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of N-acyl amino acids that are positive allosteric modulators of glycine receptors.
    Gallagher CI; Sheipouri D; Shimmon S; Rawling T; Vandenberg RJ
    Biochem Pharmacol; 2020 Oct; 180():114117. PubMed ID: 32579961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulators of the Inhibitory Glycine Receptor.
    Breitinger U; Breitinger HG
    ACS Chem Neurosci; 2020 Jun; 11(12):1706-1725. PubMed ID: 32391682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Positive Allosteric Modulators of Glycine Receptors from a High-Throughput Screen Using a Fluorescent Membrane Potential Assay.
    Stead C; Brown A; Adams C; Nickolls SJ; Young G; Kammonen J; Pryde D; Cawkill D
    J Biomol Screen; 2016 Dec; 21(10):1042-1053. PubMed ID: 27412533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Glycine-Mediated Spinal Neurotransmission for the Treatment of Chronic Pain.
    Cioffi CL
    J Med Chem; 2018 Apr; 61(7):2652-2679. PubMed ID: 28876062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids.
    Yévenes GE; Zeilhofer HU
    PLoS One; 2011; 6(8):e23886. PubMed ID: 21901142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelsemine, a principal alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific antinociception in chronic pain by acting at spinal α3 glycine receptors.
    Zhang JY; Gong N; Huang JL; Guo LC; Wang YX
    Pain; 2013 Nov; 154(11):2452-2462. PubMed ID: 23886522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine Receptors in Spinal Nociceptive Control-An Update.
    Zeilhofer HU; Werynska K; Gingras J; Yévenes GE
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators.
    Huang X; Shaffer PL; Ayube S; Bregman H; Chen H; Lehto SG; Luther JA; Matson DJ; McDonough SI; Michelsen K; Plant MH; Schneider S; Simard JR; Teffera Y; Yi S; Zhang M; DiMauro EF; Gingras J
    Nat Struct Mol Biol; 2017 Feb; 24(2):108-113. PubMed ID: 27991902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine receptors: a new therapeutic target in pain pathways.
    Lynch JW; Callister RJ
    Curr Opin Investig Drugs; 2006 Jan; 7(1):48-53. PubMed ID: 16425671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.
    Winters BL; Rawling T; Vandenberg RJ; Christie MJ; Bhola RF; Imlach WL
    Br J Pharmacol; 2018 Jun; 175(12):2337-2347. PubMed ID: 29500820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate, d-(-)-2-Amino-5-Phosphonopentanoic Acid, and
    Aubrey KR; Sheipouri D; Balle T; Vandenberg RJ; Otsu Y
    Mol Pharmacol; 2020 Dec; 98(6):719-729. PubMed ID: 33051383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine receptors and glycine transporters: targets for novel analgesics?
    Zeilhofer HU; Acuña MA; Gingras J; Yévenes GE
    Cell Mol Life Sci; 2018 Feb; 75(3):447-465. PubMed ID: 28791431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to target glycinergic neurotransmission for the treatment of chronic pain.
    Imlach WL
    Pharmacol Res; 2017 Feb; 116():93-99. PubMed ID: 27988386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel specific allosteric modulators of the glycine receptor using phage display.
    Tipps ME; Lawshe JE; Ellington AD; Mihic SJ
    J Biol Chem; 2010 Jul; 285(30):22840-5. PubMed ID: 20501662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice.
    Vincenzi F; Targa M; Romagnoli R; Merighi S; Gessi S; Baraldi PG; Borea PA; Varani K
    Neuropharmacology; 2014 Jun; 81():6-14. PubMed ID: 24486382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition Mediated by Glycinergic and GABAergic Receptors on Excitatory Neurons in Mouse Superficial Dorsal Horn Is Location-Specific but Modified by Inflammation.
    Takazawa T; Choudhury P; Tong CK; Conway CM; Scherrer G; Flood PD; Mukai J; MacDermott AB
    J Neurosci; 2017 Mar; 37(9):2336-2348. PubMed ID: 28130358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast non-genomic effects of progesterone-derived neurosteroids on nociceptive thresholds and pain symptoms.
    Charlet A; Lasbennes F; Darbon P; Poisbeau P
    Pain; 2008 Oct; 139(3):603-609. PubMed ID: 18614289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anesthetic and ethanol effects on spontaneously opening glycine receptor channels.
    Beckstead MJ; Phelan R; Trudell JR; Bianchini MJ; Mihic SJ
    J Neurochem; 2002 Sep; 82(6):1343-51. PubMed ID: 12354281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling.
    Cioffi CL
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34200954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.